Detailed information for compound 186898

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 407.466 | Formula: C22H25N5O3
  • H donors: 2 H acceptors: 6 LogP: 3.42 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCC(=O)N([C@H](C(=O)O)C)Cc1ccc(cc1)c1ccccc1c1n[nH]nn1
  • InChi: 1S/C22H25N5O3/c1-3-4-9-20(28)27(15(2)22(29)30)14-16-10-12-17(13-11-16)18-7-5-6-8-19(18)21-23-25-26-24-21/h5-8,10-13,15H,3-4,9,14H2,1-2H3,(H,29,30)(H,23,24,25,26)/t15-/m0/s1
  • InChiKey: QFCDZSRVDUYPKU-HNNXBMFYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens angiotensin II receptor, type 1 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus pyroglutamylated rfamide peptide receptor angiotensin II receptor, type 1 359 aa 403 aa 19.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Loa Loa (eye worm) hypothetical protein 0.1905 0.9838 0.9981
Trichomonas vaginalis hypothetical protein 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Mycobacterium leprae Possible transporter protein 0.0051 0.0089 0.5
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase type, putative 0.0051 0.0089 0.5
Echinococcus multilocularis mitogen activated protein kinase kinase kinase 0.1909 0.9856 1
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase type, putative 0.0051 0.0089 0.5
Echinococcus multilocularis voltage gated potassium channel 0.0051 0.0089 0.009
Schistosoma mansoni voltage-gated potassium channel 0.0051 0.0089 0.0089
Leishmania major protein kinase, putative 0.0034 0 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Loa Loa (eye worm) CAMK/CAMKL/PASK protein kinase 0.0513 0.2516 0.2485
Echinococcus granulosus mitogen activated protein kinase kinase kinase 0.1909 0.9856 1
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Loa Loa (eye worm) TKL/MLK/LZK protein kinase 0.1909 0.9856 1
Schistosoma mansoni voltage-gated potassium channel 0.0051 0.0089 0.0089
Trichomonas vaginalis adenylate cyclase type VI, putative 0.0051 0.0089 0.5
Toxoplasma gondii calcium dependent protein kinase CDPK8 0.0034 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Loa Loa (eye worm) HMP-2 protein 0.0099 0.0337 0.0254
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase type vIII, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase type IX, putative 0.0051 0.0089 0.5
Onchocerca volvulus 0.0513 0.2516 1
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase beta 2 subunit, putative 0.0051 0.0089 0.5
Entamoeba histolytica protein kinase domain containing protein 0.0034 0 0.5
Trichomonas vaginalis adenylate cyclase type IX, putative 0.0051 0.0089 0.5
Schistosoma mansoni voltage-gated potassium channel 0.0051 0.0089 0.0089
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Schistosoma mansoni hypothetical protein 0.0051 0.0089 0.0089
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase beta 1 subunit, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Echinococcus granulosus beta catenin 0.0099 0.0337 0.0342
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Trypanosoma cruzi STE/STE11 serine/threonine-protein kinase, putative 0.0034 0 0.5
Trichomonas vaginalis adenylate cyclase type IX, putative 0.0051 0.0089 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Schistosoma mansoni beta-catenin 0.0099 0.0337 0.0337
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Echinococcus granulosus voltage gated potassium channel 0.0051 0.0089 0.009
Trypanosoma cruzi STE/STE11 serine/threonine-protein kinase, putative 0.0034 0 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase type IX, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Brugia malayi Protein kinase domain containing protein 0.1909 0.9856 1
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis intestinal guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase type III, putative 0.0051 0.0089 0.5
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0051 0.0089 0.009
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Loa Loa (eye worm) hypothetical protein 0.1905 0.9838 0.9981
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0051 0.0089 0.5
Echinococcus multilocularis beta catenin 0.0099 0.0337 0.0342
Trichomonas vaginalis adenylate cyclase type III, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis soluble guanylate cyclase gcy, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Schistosoma mansoni voltage-gated potassium channel 0.0051 0.0089 0.0089
Echinococcus granulosus single minded 2 0.0051 0.0089 0.009
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Trypanosoma brucei STE group serine/threonine-protein kinase, putative 0.0055 0.0107 1
Trichomonas vaginalis adenylyl cyclase type V, putative 0.0051 0.0089 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Plasmodium falciparum protein kinase, putative 0.0034 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Brugia malayi Armadillo/beta-catenin-like repeat family protein 0.0099 0.0337 0.0254
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase, putative 0.0051 0.0089 0.5
Trichomonas vaginalis adenylate cyclase type, putative 0.0051 0.0089 0.5
Schistosoma mansoni 60S ribosomal protein L21 0.0051 0.0089 0.0089
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0051 0.0089 0.009
Trichomonas vaginalis adenylate and guanylate cyclases, putative 0.0051 0.0089 0.5
Trichomonas vaginalis guanylate cyclase, putative 0.0051 0.0089 0.5
Schistosoma mansoni voltage-gated potassium channel 0.0051 0.0089 0.0089

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 0.011 uM Tested for inhibition of Angiotensin II-induced pressor response in rabbit aorta ChEMBL. No reference
IC50 (binding) = 0.024 uM Tested for inhibition of Angiotensin II receptor, type 1 in the absence of bovine serum albumin (BSA) ChEMBL. No reference
IC50 (binding) = 0.024 uM Tested for inhibition of Angiotensin II receptor, type 1 in the absence of bovine serum albumin (BSA) ChEMBL. No reference
Inhibition (functional) = 33 % Tested for inhibition of Angiotensin II-induced pressor response in pithed rat model after 10 mg/kg peroral administration ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.